Monash IVF Group Limited (ASX:MVF)

Market Cap	261.06M
Revenue (ttm)	269.39M -0.1%
Net Income	15.16M
EPS	0.04
Shares Out	389.63M
PE Ratio	17.24
Forward PE	13.84
Dividend	0.05 (7.22%)
Ex-Dividend Date	Mar 4, 2026

Volume	971,316
Open	0.6600
Previous Close	0.6700
Day's Range	0.6550 - 0.6800
52-Week Range	0.5750 - 0.8950
Beta	0.38
Analysts	Buy
Price Target	0.77 (+13.24%)
Earnings Date	Aug 24, 2026

About Monash IVF Group

Monash IVF Group Limited engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Richmond, Australia.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2014
• Employees: 892
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: MVF

Analyst Summary

According to 6 analysts, the average rating for MVF stock is "Buy." The 12-month stock price target is $0.77, which is an increase of 13.24% from the latest price.

Price Target

$0.77

(13.24% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 28, 2026

Data Sources Report a data error